Richards, Merrill & Peterson’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,000
Closed -$30.3K 499
2024
Q4
$30.3K Buy
+2,000
New +$32.2K 0.02% 290

Other funds holding BCAT

Richards, Merrill & Peterson's BCAT Position: Q1 2025 in Review

Richards, Merrill & Peterson sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2025, closing a stake of 2,000 shares — an estimated $30.3K sold.

Richards, Merrill & Peterson first reported a position in BCAT in Q4 2024 and held it in 1 quarter. The position peaked at $30.3K in Q4 2024. 92 funds tracked by Wall St. Rank hold BCAT as of Q1 2025.

  • Richards, Merrill & Peterson reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 2,000 BlackRock Capital Allocation Term Trust shares in Q1 2025, an estimated $30.3K.
  • Richards, Merrill & Peterson first reported a position in BlackRock Capital Allocation Term Trust in Q4 2024 and held it in 1 quarter.
  • Richards, Merrill & Peterson's BlackRock Capital Allocation Term Trust position peaked at $30.3K in Q4 2024.
  • 92 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q1 2025, filed 7 May 2025.